1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Kang YU: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors CAR-CD19 T cell, CAR-BCMA T cell, CAR-GPC3 T cell - B Cell Lymphoma, B Cell Leukemia | Not applicable | Unknown | Kang YU | 18 | 2017-12-29 | 2020-10-08 |
Carcinoma, Hepatocellular (1) · Leukemia, B-Cell (1) · Lymphoma, B-Cell (1) · Neoplasms, Plasma Cell (1) · Pancreatic Neoplasms (1)
Cyclophosphamide (1) · fludarabine (1)
China (1)
Mengtao Zhou, MD (1) · Songfu Jiang, MD (1)